x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD"s CME activities. Our topics span cardiology, diabetes, oncology, women"s health and more. And our CME library is continuously growing, every quarter.

science & medicine medicine

All Episodes

00:00:00

Guideline recommendations for first-line treatment of...

CME/CE ·

2024/11/27

Host: Luis Paz-Ares, MD, PhD Host: Helena Yu, MD Host: Matthew Gubens, MD, MS This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN), focuses on translating oncology guidelines into practical strategies for treating non-small cell lung cancer (NSCLC). Participants will learn how to integrate clinical trial data into guideline-concordant testing and treatment plans for patients with resectable and metastatic NSCLC. The program

en

00:00:00

Insights from global key opinion leaders on...

CME/CE ·

2024/11/27

Host: Luis Paz-Ares, MD, PhD Host: Helena Yu, MD Host: Matthew Gubens, MD, MS This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN), focuses on translating oncology guidelines into practical strategies for treating non-small cell lung cancer (NSCLC). Participants will learn how to integrate clinical trial data into guideline-concordant testing and treatment plans for patients with resectable and metastatic NSCLC. The program

en

00:00:00

Incorporation of guidelines-concordant immunotherapy...

CME/CE ·

2024/11/27

Host: Luis Paz-Ares, MD, PhD Host: Helena Yu, MD Host: Matthew Gubens, MD, MS This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN), focuses on translating oncology guidelines into practical strategies for treating non-small cell lung cancer (NSCLC). Participants will learn how to integrate clinical trial data into guideline-concordant testing and treatment plans for patients with resectable and metastatic NSCLC. The program

en

00:00:00

Application of guidelines-recommended broad molecular...

CME/CE ·

2024/11/27

Host: Luis Paz-Ares, MD, PhD Host: Helena Yu, MD Host: Matthew Gubens, MD, MS This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN), focuses on translating oncology guidelines into practical strategies for treating non-small cell lung cancer (NSCLC). Participants will learn how to integrate clinical trial data into guideline-concordant testing and treatment plans for patients with resectable and metastatic NSCLC. The program

en

00:00:00

Guidelines-recommended targeted therapies as...

CME/CE ·

2024/11/27

Host: Luis Paz-Ares, MD, PhD Host: Helena Yu, MD Host: Matthew Gubens, MD, MS This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN), focuses on translating oncology guidelines into practical strategies for treating non-small cell lung cancer (NSCLC). Participants will learn how to integrate clinical trial data into guideline-concordant testing and treatment plans for patients with resectable and metastatic NSCLC. The program

en

00:00:00

Incorporation of guidelines-concordant care for...

CME/CE ·

2024/11/27

Host: Luis Paz-Ares, MD, PhD Host: Helena Yu, MD Host: Matthew Gubens, MD, MS This online CME activity, presented in collaboration with the National Comprehensive Cancer Network (NCCN), focuses on translating oncology guidelines into practical strategies for treating non-small cell lung cancer (NSCLC). Participants will learn how to integrate clinical trial data into guideline-concordant testing and treatment plans for patients with resectable and metastatic NSCLC. The program

en

00:00:00

FCS and SHTG: Are We Meeting the Need?

CME/CE ·

2024/11/22

Guest: Ira J. Goldberg, MD Guest: Kausik Ray, MBChB, MD, MPhil Guest: Christie Ballantyne Patients with familial chylomicronemia (FCS) and severe hypertriglyceridemia (SHTG) suffer from multiple complications, the most severe being acute pancreatitis. Current therapeutic agents, which include fibrates, omega-3 fatty acids, statins, and niacin, are generally ineffective. There are new developments with investigational siRNA therapeutics that silence APOC3, a key regulator of

en

00:00:00

Optimizing Outcomes in Patients With IgAN: Novel...

CME/CE ·

2024/11/21

Host: Jürgen Floege, MD Guest: Jonathan Barratt, PhD Given that IgA nephropathy is a leading cause of kidney failure, early diagnosis and treatment are essential. In the landscape of the many evolving treatment guidelines, how can nephrologists apply emerging evidence and utilize newer therapies to achieve proteinuria remission and maintain eGFR to improve the outcomes of their patients? Hear the experts answer these questions by reviewing a real-world clinical patient case.

en

00:00:00

Current Experiences in Identifying and Treating Itch...

CME/CE ·

2024/11/21

Host: James Burton, DM, FRCP Guest: Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS Patients with chronic kidney disease may be experiencing severe itch, known as CKD-associated pruritus (CKD-aP). Itching and related symptoms, such as reduced sleep and depression, may be causing a significant negative impact on their quality of life. Join our experts as they use real-world patient cases to illustrate how to identify and treat itch, provide relief from itch-related symptoms, and improve

en

00:00:00

Empowering Choices: Navigating Early-Stage HR+, HER2-...

CME/CE ·

2024/10/31

Host: Joyce O'Shaughnessy, MD Hormone receptor-positive, HER2-negative cancer is the most common subtype of breast cancer. Initial treatment consists of surgery with or without radiotherapy or chemoradiotherapy, followed by adjuvant endocrine therapy for 5 to 10 years. Although endocrine therapy improves outcomes in these patients, recurrence is high (40% to 60% of patients). In disease with no BRCA mutation, treatment intensification by adding a CDK4/6 inhibitor to endocrine

en

00:00:00

Unveiling the Latest Advancements in CKD-Associated...

CME/CE ·

2024/10/18

Host: Stefan H. Jacobson, MD, PhD Guest: Carlos Narváez Mejía, MD Chronic kidney disease-associated pruritus (CKD-aP) is an underreported and underdiagnosed condition that affects a significant proportion of patients with advanced kidney disease undergoing dialysis. But with the approval of difelikefalin, many patients have experienced symptom improvement not only in their itching but in their quality of life. Join the experts as they review the newest real-world data and clinical

en

00:00:00

Diagnosing COPD: From Symptoms to Assessment & the...

CME/CE ·

2024/10/18

Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biologically-targeted therapies to be available soon, it is important to address current educational needs related to COPD. This includes knowledge of T2 inflammation in COPD, understanding the clinician’s role in assessing patients for inflammatory

en

00:00:00

Limitations of Current Treatments: FDA-Approved and...

CME/CE ·

2024/10/15

Guest: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Inconsistent Outcomes: How Ignoring Guidelines Leads...

CME/CE ·

2024/10/15

Guest: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Conversations With Patients About PTSD, Screening,...

CME/CE ·

2024/10/15

Guest: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Modeling Activity: Quality Conversations With...

CME/CE ·

2024/10/15

Guest: Roger McIntyre, MD Guest: Joseph F. Goldberg, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Prevalence and Burden of PTSD in Women: Focus on...

CME/CE ·

2024/10/15

Guest: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Setting the Stage: Unmet Needs in the Treatment of...

CME/CE ·

2024/10/15

Guest: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Proactively Uncovering Potential Traumatic...

CME/CE ·

2024/10/15

Guest: Roger McIntyre, MD Guest: Joseph F. Goldberg, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Role of PCP & Ob-Gyn With Women at Risk for PTSD:...

CME/CE ·

2024/10/15

Host: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

286 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事